EDAP TMS SA (EDAP +19.7%) pops today after earlier reporting test data showing high survival and...

|About: EDAP TMS S.A. (EDAP)|By:, SA News Editor

EDAP TMS SA (EDAP +19.7%) pops today after earlier reporting test data showing high survival and salvage rates for patients given its high-intensity focused ultrasound therapy to treat prostate cancer. The study was electronically published in the Journal of Urology, the Official Journal of the American Urological Association.